Evogene Ltd. files 424B5

Evogene Ltd. is offering to sell up to $2,926,500 of its ordinary shares through an "at the market" offering. The company intends to use the net proceeds for research and development, working capital, investments in subsidiaries, sales and marketing, and general corporate purposes.